Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 15, 2008
[Effects of the anticholinesterase drug neuromidin in patients with schizophrenia with marked neurocognitive deficits]M A Morozova, A G Beniashvili, G E Rupchev, et al.
Stomatologiia|July 20, 2019
[Growing of murine tooth in situ by homotopic transplantation of embryonic germ]G S Runova, L V Kuznetzova, M A Morozova, et al.
Thescientificworldjournal|January 16, 2019
Mechanical Transformation of Compounds Leading to Physical, Chemical, and Biological Changes in Pharmaceutical SubstancesA V Syroeshkin, E V Uspenskaya, T V Pleteneva, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 9, 2025
[The effect of psychopharmacological load on various aspects of the condition in patients with depressive syndrome during remission]M A Morozova, E Yu Nikonova, G Ch Ashurova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|July 24, 2004
[A change of immune profile of patients with schizophrenia during treatment]G I Koliaskina, T P Sekirina, L V Androsova, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|May 16, 2007
[The influence of atypical neuroleptics on the immune system of patients with schizophrenia]G I Koliaskina, T P Sekirina, L V Androsova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 18, 2024
[Natural history of spinal muscular atrophy type I]D V Vlodavets, Yu N Linkova, A V Zinkina-Orikhan, et al.
Neuroscience Letters|March 21, 2020
Decrease in 130 kDa- amyloid protein precursor protein (APP) and APP protein ratio in schizophrenia plateletsE B Tereshkina, I S Boksha, T A Prokhorova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 27, 2018
[The activity of erythrocyte and platelet glutathione reductase and glutathione-S-transferase in paranoid schizophrenia]O K Savushkina, I S Boksha, T A Prokhorova, et al.
Pageof 5